Benefit of Tacrolimus/Myocophenolate To Reduce Cardiac Allograft Vasculopathy after Heart Transplantation

被引：0
|
作者：
Patel, J. [1 ]
Kittleson, M. [1 ]
Rafiei, M. [1 ]
Osborne, A. [1 ]
Aaronson, A. [1 ]
Chang, D. H. [1 ]
Azarbal, B. [1 ]
Czer, L. [1 ]
Moriguchi, J. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2013年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
114
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [1] BENEFIT OF TACROLIMUS/MYCOPHENOLATE TO REDUCE CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Aaronson, Alistair
    Kittleson, Michelle
    Patel, Jignesh
    Rafiei, Matthew
    Osborne, Ashley
    Chang, David
    Czer, Lawrence
    Kobashigawa, Jon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E798 - E798
  • [2] Proliferation Signal Inhibitors Reduce Severity of Cardiac Allograft Vasculopathy after Heart Transplantation
    Patel, J.
    Kittleson, M.
    Rafiei, M.
    Osborne, A.
    Chang, D. H.
    Czer, L.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S50 - S50
  • [3] DYSLIPIDEMIA AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Simonenko, M.
    Sazonova, Y.
    Fedotov, P.
    Krasnov, V.
    Rubinchik, V.
    Pervunina, T.
    Berezina, A.
    Privorotskii, V.
    Zverev, D.
    Sitnikova, M.
    Nikolaev, G.
    Gordeev, M.
    Karpenko, M.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 11 - 11
  • [4] OBESITY AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Carr, S.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 158 - 158
  • [5] Cardiac allograft vasculopathy after heart transplantation: Is it really ominous?
    Lim, Ju Yong
    Jung, Sung Ho
    Kim, Min Seok
    Park, Jeong-Jun
    Yun, Tae-Jin
    Kim, Jae Joong
    Lee, Jae Won
    CLINICAL TRANSPLANTATION, 2017, 31 (02)
  • [6] Accelerated cardiac allograft vasculopathy after pediatric heart transplantation
    Zablah, Jenny E.
    Everitt, Melanie D.
    Wilson, Neil
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (11) : 2984 - 2985
  • [7] PET Assessment of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Kushwaha, Sudhir S.
    JACC-HEART FAILURE, 2023, 11 (05) : 566 - 568
  • [8] Factors associated with the cardiac allograft vasculopathy after heart transplantation
    Szczurek, W.
    Gasior, M.
    Skrzypek, M.
    Romuk, E.
    Zembala, M.
    Jurkiewicz, B. Szygula
    EUROPEAN HEART JOURNAL, 2020, 41 : 2697 - 2697
  • [9] The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation
    Spitaleri, Giosafat
    Farrero Torres, Marta
    Sabatino, Mario
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (11) : 1367 - 1376
  • [10] Factors associated with cardiac allograft vasculopathy after heart transplantation
    Szczurek-Wasilewicz, Wioletta
    Hawranek, Michal
    Skrzypek, Michal
    Hrapkowicz, Tomasz
    Gasior, Mariusz
    Warmusz, Oliwia
    Szygula-Jurkiewicz, Bozena
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2022, 18 (03): : 237 - 245
12345